Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Cardinal Health (CAH) Share Price
News headlines about Cardinal Health (NYSE:CAH) have trended somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cardinal Health earned a daily sentiment score of 0.09 on Accern’s scale. Accern also assigned media stories about the company an impact score of 46.2524808064397 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
These are some of the media stories that may have impacted Accern’s scoring:
- Cardinal Health (CAH) Earns Hold Rating from Robert W. Baird (americanbankingnews.com)
- [$$] Dentsply Sirona Taps Outsider for CEO Following Forced Resignations (finance.yahoo.com)
- Cardinal Health Reaches Analyst Target Price (nasdaq.com)
- Cardinal Health Inc Expected to Earn Q3 2018 Earnings of $1.78 Per Share (CAH) (americanbankingnews.com)
- Cardinal Health Inc (CAH) Receives Consensus Recommendation of “Hold” from Brokerages (americanbankingnews.com)
Several analysts have recently commented on the company. Evercore ISI assumed coverage on Cardinal Health in a research report on Thursday, January 4th. They issued an “in-line” rating and a $67.00 target price for the company. Zacks Investment Research raised Cardinal Health from a “sell” rating to a “hold” rating in a research report on Wednesday, November 8th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardinal Health in a research report on Thursday, October 12th. Cowen raised Cardinal Health to a “buy” rating and set a $74.00 target price for the company in a research report on Tuesday, October 10th. Finally, Mizuho set a $70.00 target price on Cardinal Health and gave the stock a “hold” rating in a research report on Tuesday, October 24th. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $73.58.
Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.00 by $0.09. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The business had revenue of $32.64 billion during the quarter, compared to analyst estimates of $33.48 billion. During the same period last year, the company earned $1.24 earnings per share. Cardinal Health’s quarterly revenue was up 1.9% compared to the same quarter last year. sell-side analysts anticipate that Cardinal Health will post 5.08 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, January 15th. Investors of record on Tuesday, January 2nd were issued a dividend of $0.4624 per share. The ex-dividend date was Friday, December 29th. This represents a $1.85 annualized dividend and a dividend yield of 2.58%. Cardinal Health’s dividend payout ratio is 53.94%.
ILLEGAL ACTIVITY WARNING: This story was first posted by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at https://www.watchlistnews.com/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-cardinal-health-cah-share-price/1812869.html.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.